|
1
|
Olar A and Aldape KD: Using the molecular
classification of glioblastoma to inform personalized treatment. J
Pathol. 232:165–177. 2014. View Article : Google Scholar :
|
|
2
|
Jones TS and Holland EC: Standard of care
therapy for malignant glioma and its effect on tumor and stromal
cells. Oncogene. 31:1995–2006. 2012. View Article : Google Scholar
|
|
3
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sasportas LS, Kasmieh R, Wakimoto H,
Hingtgen S, van de Water JA, Mohapatra G, Figueiredo JL, Martuza
RL, Weissleder R and Shah K: Assessment of therapeutic efficacy and
fate of engineered human mesenchymal stem cells for cancer therapy.
Proc Natl Acad Sci USA. 106:4822–4827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Murphy AM and Rabkin SD: Current status of
gene therapy for brain tumors. Transl Res. 161:339–354. 2013.
View Article : Google Scholar :
|
|
6
|
Bexell D, Svensson A and Bengzon J: Stem
cell-based therapy for malignant glioma. Cancer Treat Rev.
39:358–365. 2013. View Article : Google Scholar
|
|
7
|
Bexell D, Gunnarsson S, Tormin A, Darabi
A, Gisselsson D, Roybon L, Scheding S and Bengzon J: Bone marrow
multipotent mesenchymal stroma cells act as pericyte-like migratory
vehicles in experimental gliomas. Mol Ther. 17:183–190. 2009.
View Article : Google Scholar
|
|
8
|
Kim SM, Woo JS, Jeong CH, Ryu CH, Lim JY
and Jeun SS: Effective combination therapy for malignant glioma
with TRAIL-secreting mesenchymal stem cells and lipoxygenase
inhibitor MK886. Cancer Res. 72:4807–4817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamizo A, Marini F, Amano T, Khan A,
Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, et
al: Human bone marrow-derived mesenchymal stem cells in the
treatment of gliomas. Cancer Res. 65:3307–3318. 2005.PubMed/NCBI
|
|
10
|
Cheng M and Qin G: Progenitor cell
mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit.
Prog Mol Biol Transl Sci. 111:243–264. 2012. View Article : Google Scholar
|
|
11
|
Haanstra KG, Hofman SO, Lopes Estêvão DM,
Blezer EL, Bauer J, Yang LL, Wyant T, Csizmadia V, ‘t Hart BA and
Fedyk ER: Antagonizing the α4β1 integrin, but not α4β7, inhibits
leukocytic infiltration of the central nervous system in rhesus
monkey experimental autoimmune encephalomyelitis. J Immunol.
190:1961–1973. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takeichi T, Mocevicius P, Deduchovas O,
Salnikova O, Castro-Santa E, Büchler MW, Schmidt J and Ryschich E:
αL β2 integrin is indispensable for CD8+ T-cell
recruitment in experimental pancreatic and hepatocellular cancer.
Int J Cancer. 130:2067–2076. 2012. View Article : Google Scholar
|
|
13
|
Couture P, Paradis-Massie J, Oualha N and
Thibault G: Adhesion and transcellular migration of neutrophils and
B lymphocytes on fibroblasts. Exp Cell Res. 315:2192–2206. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Engelhardt B: Molecular mechanisms
involved in T cell migration across the blood-brain barrier. J
Neural Transm. 113:477–485. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Klemke M, Weschenfelder T, Konstandin MH
and Samstag Y: High affinity interaction of integrin alpha4beta1
(VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances
migration of human melanoma cells across activated endothelial cell
layers. J Cell Physiol. 212:368–374. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu Y, Cheng P, Xue YX and Liu YH: Glioma
cells promote the expression of vascular cell adhesion molecule-1
on bone marrow-derived mesenchymal stem cells: a possible mechanism
for their tropism toward gliomas. J Mol Neurosci. 48:127–135. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ilina O and Friedl P: Mechanisms of
collective cell migration at a glance. J Cell Sci. 122:3203–3208.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu Y, Cheng P, Ma JC, Xue YX and Liu YH:
Platelet-derived growth factor BB mediates the glioma-induced
migration of bone marrow-derived mesenchymal stem cells by
promoting the expression of vascular cell adhesion molecule-1
through the PI3K, P38 MAPK and NF-κB pathways. Oncol Rep.
30:2755–2764. 2013.PubMed/NCBI
|
|
19
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop Dj and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nora CC, Camassola M, Bellagamba B, Ikuta
N, Christoff AP, Meirelles LS, Ayres R, Margis R and Nardi NB:
Molecular analysis of the differentiation potential of murine
mesenchymal stem cells from tissues of endodermal or mesodermal
origin. Stem Cells Dev. 21:1761–1768. 2012. View Article : Google Scholar
|
|
22
|
Birnbaum T, Roider J, Schankin CJ, Padovan
CS, Schichor C, Goldbrunner R and Straube A: Malignant gliomas
actively recruit bone marrow stromal cells by secreting angiogenic
cytokines. J Neurooncol. 83:241–247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Umesh A, Thompson MA, Chini EN, Yip KP and
Sham JS: Integrin ligands mobilize Ca2+ from ryanodine
receptor-gated stores and lysosome-related acidic organelles in
pulmonary arterial smooth muscle cells. J Biol Chem.
281:34312–34323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishiya N, Kiosses WB, Han J and Ginsberg
MH: An α4 integrin-paxillin-Arf-GAP complex restricts Rac
activation to the leading edge of migrating cells. Nat Cell Biol.
7:343–352. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Garmy-Susini B, Avraamides CJ,
Desgrosellier JS, Schmid MC, Foubert P, Ellies LG, Lowy AM, Blair
SL, Vandenberg SR, Datnow B, et al: PI3Kα activates integrin α4β1
to establish a metastatic niche in lymph nodes. Proc Natl Acad Sci
USA. 110:9042–9047. 2013. View Article : Google Scholar
|
|
26
|
James WG, Bullard DC and Hickey MJ:
Critical role of the α4 integrin/VCAM-1 pathway in cerebral
leukocyte trafficking in lupus-prone MRL/fas(lpr) mice. J Immunol.
170:520–527. 2003. View Article : Google Scholar
|
|
27
|
Bernhart E, Damm S, Wintersperger A,
DeVaney T, Zimmer A, Raynham T, Ireson C and Sattler W: Protein
kinase D2 regulates migration and invasion of U87MG glioblastoma
cells in vitro. Exp Cell Res. 319:2037–2048. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang YB, Hu Y, Li Z, Wang P, Xue YX, Yao
YL, Yu B and Liu YH: Artemether combined with shRNA interference of
vascular cell adhesion molecule-1 significantly inhibited the
malignant biological behavior of human glioma cells. PLoS One.
8:e608342013. View Article : Google Scholar : PubMed/NCBI
|
